Prolonged Continuous Electrocardiographic Monitoring Prior to Transcatheter Aortic Valve Replacement The PARE Study

被引:18
作者
Asmarats, Lluis [1 ]
Nault, Isabelle [1 ]
Ferreira-Neto, Alfredo Nunes [1 ]
Muntane-Carol, Guillem [1 ]
del Val, David [1 ]
Junquera, Lucia [1 ]
Paradis, Jean-Michel [1 ]
Delarochelliere, Robert [1 ]
Mohammadi, Siamak [1 ]
Kalavrouziotis, Dimitri [1 ]
Dumont, Eric [1 ]
Pelletier-Beaumont, Emilie [1 ]
Philippon, Francois [1 ]
Rodes-Cabau, Josep [1 ]
机构
[1] Laval Univ, Quebec Heart & Lung Inst, 2725 Chemin Ste Foy, Quebec City, PQ G1V 4GS, Canada
关键词
ambulatory electrocardiographic; aortic valve stenosis; arrhythmia; monitoring; pacemaker; transcatheter aortic valve replacement; ATRIAL-FIBRILLATION; VENTRICULAR-ARRHYTHMIAS; CONDUCTION DISTURBANCES; IMPLANTATION; STENOSIS; MANAGEMENT; FUTURE;
D O I
10.1016/j.jcin.2020.03.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine, using continuous electrocardiographic monitoring (CEM) pre-transcatheter aortic valve replacement (TAVR), the incidence and type of unknown pre-existing arrhythmic events (AEs) in TAVR candidates, and to evaluate the occurrence and impact of therapeutic changes secondary to the detection of AEs pre-TAVR. BACKGROUND Scarce data exist on the arrhythmic burden of TAVR candidates (pre-procedure). METHODS This was a prospective study including 106 patients with severe aortic stenosis and no prior permanent pacemaker screened for TAVR. A prolonged (1 week) CEM was implanted within the 3 months pre-TAVR. Following heart team evaluation, 90 patients underwent elective TAVR. RESULTS New AEs were detected by CEM in 51 (48.1%) patients, leading to a treatment change in 14 of 51 (27.5%) patients. Atrial fibrillation or tachycardia was detected in 8 of 79 (10.1%) patients without known atrial fibrillation or tachycardia, and nonsustained ventricular arrhythmias were detected in 31 (29.2%) patients. Significant bradyarrhythmias were observed in 22 (20.8%) patients, leading to treatment change and permanent pacemaker in 8 of 22 (36.4%) and 4 of 22 (18.2%) patients, respectively. The detection of bradyarrhythmias increased up to 30% and 47% among those patients with pre-existing first-degree atrioventricular block and right bundle branch block, respectively. Chronic renal failure, higher valve calcification, and left ventricular dysfunction determined (or tended to determine) an increased risk of AEs pre-TAVR (p = 0.028, 0.052, and 0.069, respectively). New onset AEs post-TAVR occurred in 22.1% of patients, and CEM pre-TAVR allowed early arrhythmia diagnosis in one-third of them. CONCLUSIONS Prolonged CEM in TAVR candidates allowed identification of previously unknown AEs in nearly one-half of the patients, leading to prompt therapeutic measures (pre-TAVR) in about one-fourth of them. Pre-existing conduction disturbances (particularly right bundle branch block) and chronic renal failure were associated with a higher burden of AEs. (C) 2020 by the American College of Cardiology Foundation.
引用
收藏
页码:1763 / 1773
页数:11
相关论文
共 26 条
[1]  
Al-Khatib Sana M, 2018, J Am Coll Cardiol, V72, pe91, DOI 10.1016/j.jacc.2017.10.054
[2]   Conduction Disturbances After Transcatheter Aortic Valve Replacement Current Status and Future Perspectives [J].
Auffret, Vincent ;
Puri, Rishi ;
Urena, Marina ;
Chamandi, Chekrallah ;
Rodriguez-Gabella, Tania ;
Philippon, Francois ;
Rodes-Cabau, Josep .
CIRCULATION, 2017, 136 (11) :1049-+
[3]   Reported Versus "Real" Incidence of New Pacemaker Implantation Post-Transcatheter Aortic Valve Replacement [J].
Chamandi, Chekrallah ;
Regueiro, Ander ;
Auffret, Vincent ;
Rodriguez-Gabella, Tania ;
Chiche, Olivier ;
Barria, Alberto ;
Cote, Melanie ;
Philippon, Francois ;
Puri, Rishi ;
Rodes-Cabau, Josep .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (21) :2387-2389
[4]   Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation The Critical Role of Valve Implantation Height [J].
De Torres-Alba, Fernando ;
Kaleschke, Gerrit ;
Diller, Gerhard Paul ;
Vormbrock, Julia ;
Orwat, Stefan ;
Radke, Robert ;
Reinke, Florian ;
Fischer, Dieter ;
Reinecke, Holger ;
Baumgartner, Helmut .
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (08) :805-813
[5]   2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities [J].
Epstein, Andrew E. ;
DiMarco, John P. ;
Ellenbogen, Kenneth A. ;
Estes, N. A. Mark, III ;
Freedman, Roger A. ;
Gettes, Leonard S. ;
Gillinov, A. Marc ;
Gregoratos, Gabriel ;
Hammill, Stephen C. ;
Hayes, David L. ;
Hlatky, Mark A. ;
Newby, L. Kristin ;
Page, Richard L. ;
Schoenfeld, Mark H. ;
Silka, Michael J. ;
Stevenson, Lynne Warner ;
Sweeney, Michael O. ;
Tracy, Cynthia M. ;
Epstein, Andrew E. ;
Darbar, Dawood ;
DiMarco, John P. ;
Dunbar, Sandra B. ;
Estes, N. A. Mark, III ;
Karasik, Pamela E. ;
Link, Mark S. ;
Marine, Joseph E. ;
Schoenfeld, Mark H. ;
Shanker, Amit J. ;
Silka, Michael J. ;
Stevenson, Lynne Warner ;
Stevenson, William G. ;
Varosy, Paul D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (03) :E6-E75
[6]   European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) [J].
Gorenek, Bulent ;
Pelliccia, Antonio ;
Benjamin, Emelia J. ;
Boriani, Giuseppe ;
Crijns, Harry J. ;
Fogel, Richard I. ;
Van Gelder, Isabelle C. ;
Halle, Martin ;
Kudaiberdieva, Gulmira ;
Lane, Deirdre A. ;
Larsen, Torben Bjerregaard ;
Lip, Gregory Y. H. ;
Lochen, Maja-Lisa ;
Marin, Francisco ;
Niebauer, Josef ;
Sanders, Prashanthan ;
Tokgozoglu, Lale ;
Vos, Marc A. ;
Van Wagoner, David R. ;
Fauchier, Laurent ;
Savelieva, Irina ;
Goette, Andreas ;
Agewall, Stefan ;
Chiang, Chern-En ;
Figueiredo, Marcio ;
Stiles, Martin ;
Dickfeld, Timm ;
Patton, Kristen ;
Piepoli, Massimo ;
Corra, Ugo ;
Marques-Vidal, Pedro Manuel ;
Faggiano, Pompilio ;
Schmid, Jean-Paul ;
Abreu, Ana .
EUROPACE, 2017, 19 (02) :190-225
[7]   Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score [J].
Kaplan, Rachel M. ;
Koehler, Jodi ;
Ziegler, Paul D. ;
Sarkar, Shantanu ;
Zweibel, Steven ;
Passman, Rod S. .
CIRCULATION, 2019, 140 (20) :1639-1646
[8]   Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document [J].
Kappetein, A. Pieter ;
Head, Stuart J. ;
Genereux, Philippe ;
Piazza, Nicolo ;
van Mieghem, Nicolas M. ;
Blackstone, Eugene H. ;
Brott, Thomas G. ;
Cohen, David J. ;
Cutlip, Donald E. ;
van Es, Gerrit-Anne ;
Hahn, Rebecca T. ;
Kirtane, Ajay J. ;
Krucoff, Mitchell W. ;
Kodali, Susheel ;
Mack, Michael J. ;
Mehran, Roxana ;
Rodes-Cabau, Josep ;
Vranckx, Pascal ;
Webb, John G. ;
Windecker, Stephan ;
Serruys, Patrick W. ;
Leon, Martin B. .
EUROPEAN HEART JOURNAL, 2012, 33 (19) :2403-+
[9]   2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [J].
Kirchhof, Paulus ;
Benussi, Stefano ;
Kotecha, Dipak ;
Ahlsson, Anders ;
Atar, Dan ;
Casadei, Barbara ;
Castella, Manuel ;
Diener, Hans-Christoph ;
Heidbuchel, Hein ;
Hendriks, Jeroen ;
Hindricks, Gerhard ;
Manolis, Antonis S. ;
Oldgren, Jonas ;
Popescu, Bogdan Alexandru ;
Schotten, Ulrich ;
Van Putte, Bart ;
Vardas, Panagiotis .
EUROPEAN HEART JOURNAL, 2016, 37 (38) :2893-+
[10]  
Kusumoto FM, 2019, J AM COLL CARDIOL, V74, pE51, DOI 10.1016/j.jacc.2018.10.044